TrialJournal for immunotherapy of cancer2025

Immunological biomarkers of response and resistance to treatment with cabozantinib and nivolumab in recurrent endometrial cancer.

Vladimir Roudko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.